ESTIMATION OF G-CSF EFFECTIVENESS IN REDUCING NEUTROPENIA HOSPITALIZATION AMONG NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS TREATED WITH ANTHRACYCLINE-BASED CHEMOTHERAPY

被引：0
|
作者：
Pan, X. [1 ]
Brooks, J. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72101-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A25 / A25
页数：1
相关论文
共 50 条
  • [31] Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma
    Aurlien, E
    Holte, H
    Pharo, A
    Kvaloy, S
    Jakobsen, E
    Smeland, EB
    Kvalheim, G
    BONE MARROW TRANSPLANTATION, 1998, 21 (09) : 873 - 878
  • [32] Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL)
    Rossi, G
    Donisi, A
    Casari, S
    Re, A
    Stellini, R
    Cadeo, GP
    Carosi, G
    HAEMATOLOGICA, 1998, 83 (04) : 317 - 322
  • [33] Breast Cancer in Patients with Hodgkin's Lymphoma Predominantly Treated with Anthracycline-Based Chemotherapy with or without Radiotherapy: A Preliminary Analysis
    Vassilakopoulos, T. P.
    Pangalis, G. A.
    Angelopoulou, M. K.
    Pappas, P.
    Kokoris, S., I
    Pazaiti, A.
    Konstantopoulos, K.
    Karles, D.
    Papalampros, E.
    Kontos, M.
    CANCER RESEARCH, 2009, 69 (24) : 846S - 846S
  • [34] rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin's lymphoma
    Zhu, Jun
    Hao, Si-Guo
    Hu, Jiong
    Zhuang, Jing-Li
    Wang, Chun
    Bai, Hai-Tao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8371 - 8377
  • [35] Intensive chemotherapy and G-CSF for HIV-associated non-Hodgkin's lymphoma (LNHIV-91 regimen)
    Oksenhendler, E
    Gerard, L
    Dubreuil, ML
    Barateau, V
    Levy, Y
    Ferchal, F
    Clauvel, JP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 103 - 103
  • [36] Randomized trial of granulocyte-colony stimulating factor (G-CSF) added to CHOP in elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
    Doorduijn, JK
    van der Holt, B
    van der Hem, KG
    van Imhoff, GW
    Kramer, MHH
    van Oers, MHJ
    Ossenkoppele, GJ
    Schaafsma, MR
    Verdonck, LF
    Verhoef, GEG
    Steijaert, MMC
    Lowenberg, B
    Sonneveld, P
    BLOOD, 2000, 96 (11) : 133A - 133A
  • [37] Incidence of Febrile Neutropenia and Myelotoxicity of Chemotherapy: A Meta-Analysis of Biosimilar G-CSF Studies in Breast Cancer, Lung Cancer, and Non-Hodgkin's Lymphoma
    Engert, Andreas
    del Giglio, Auro
    Bias, Peter
    Lubenau, Heinz
    Gatzemeier, Ulrich
    Heigener, David
    ONKOLOGIE, 2009, 32 (10): : 599 - 604
  • [38] MANAGEMENTS OF FEBRILE NEUTROPENIA AMONG NON-HODGKIN'S LYMPHOMA PATIENTS IN TAIWAN
    Lin, W. T.
    Hsiao, F. Y.
    Chiang, S. C.
    Wen, Y. W.
    VALUE IN HEALTH, 2012, 15 (07) : A618 - A618
  • [39] Febrile neutropenia and reduced dose intensity in patients with aggressive non-Hodgkin's lymphoma (NHL) treated with CHOP and CNOP.
    Dale, DC
    Crawford, J
    Agboola, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 582S - 582S
  • [40] Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma
    Donato, ML
    Champlin, RE
    Van Besien, KW
    Korbling, M
    Cabanillas, F
    Anderlini, P
    Gajewski, JG
    Lauppe, J
    Durett, A
    Andersson, B
    Giralt, S
    Khouri, I
    Hagemeister, F
    Romaguera, JE
    Sarris, A
    McLaughlin, P
    Younes, A
    Ippoliti, C
    Blamble, DA
    Hester, J
    Gee, A
    Rodriguez, MA
    LEUKEMIA & LYMPHOMA, 1999, 35 (3-4) : 317 - 324
12345